Literature DB >> 24614580

Paclitaxel isomerisation in polymeric micelles based on hydrophobized hyaluronic acid.

Daniela Smejkalová1, Kristina Nešporová2, Martina Hermannová2, Gloria Huerta-Angeles2, Dagmar Cožíková2, Lucie Vištejnová2, Barbora Safránková2, Jaroslav Novotný2, Jiří Kučerík3, Vladimír Velebný2.   

Abstract

Physical and chemical structure of paclitaxel (PTX) was studied after its incorporation into polymeric micelles made of hyaluronic acid (HA) (Mw=15 kDa) grafted with C6 or C18:1 acyl chains. PTX was physically incorporated into the micellar core by solvent evaporation technique. Maximum loading capacity for HAC6 and HAC18:1 was determined to be 2 and 14 wt.%, respectively. The loading efficiency was higher for HAC18:1 and reached 70%. Independently of the derivative, loaded HA micelles had spherical size of approximately 60-80 nm and demonstrated slow and sustained release of PTX in vitro. PTX largely changed its form from crystalline to amorphous after its incorporation into the micelle's interior. This transformation increased PTX sensitivity towards stressing conditions, mainly to UV light exposure, during which the structure of amorphous PTX isomerized and formed C3C11 bond within its structure. In vitro cytotoxicity assay revealed that polymeric micelles loaded with PTX isomer had higher cytotoxic effect to normal human dermal fibroblasts (NHDF) and human colon carcinoma cells (HCT-116) than the same micelles loaded with non-isomerized PTX. Further observation indicated that PTX isomer influenced in different ways cell morphology and markers of cell cycle. Taken together, PTX isomer loaded in nanocarrier systems may have improved anticancer activity in vivo than pure PTX.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hyaluronan; Hyaluronic acid (PubChem CID: 453617); Isomer; Paclitaxel; Paclitaxel (PubChem CID: 44155032); Polymeric micelle; Stability

Mesh:

Substances:

Year:  2014        PMID: 24614580     DOI: 10.1016/j.ijpharm.2014.03.024

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

Review 1.  Basics to advances in nanotherapy of colorectal cancer.

Authors:  Ankita Tiwari; Shivani Saraf; Ankit Jain; Pritish K Panda; Amit Verma; Sanjay K Jain
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

Review 2.  Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs.

Authors:  Avinash Gothwal; Iliyas Khan; Umesh Gupta
Journal:  Pharm Res       Date:  2015-09-17       Impact factor: 4.200

3.  131I-Traced PLGA-Lipid Nanoparticles as Drug Delivery Carriers for the Targeted Chemotherapeutic Treatment of Melanoma.

Authors:  Haiyan Wang; Weizhong Sheng
Journal:  Nanoscale Res Lett       Date:  2017-05-19       Impact factor: 4.703

4.  Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery.

Authors:  Gamze Varan; Juan M Benito; Carmen Ortiz Mellet; Erem Bilensoy
Journal:  Beilstein J Nanotechnol       Date:  2017-07-13       Impact factor: 3.649

Review 5.  An Effective Translation: The Development of Hyaluronan-Based Medical Products From the Physicochemical, and Preclinical Aspects.

Authors:  Gloria Huerta-Ángeles; Kristina Nešporová; Gabriela Ambrožová; Lukas Kubala; Vladimir Velebný
Journal:  Front Bioeng Biotechnol       Date:  2018-05-17

6.  Design of Experiments-Assisted Development of Clotrimazole-Loaded Ionic Polymeric Micelles Based on Hyaluronic Acid.

Authors:  Laura Catenacci; Giorgio Marrubini; Milena Sorrenti; Silvia Rossi; Giuseppina Sandri; Franca Ferrari; Valentina Fagnani; Caterina Valentino; Maria Cristina Bonferoni
Journal:  Nanomaterials (Basel)       Date:  2020-03-29       Impact factor: 5.076

7.  Nanomicelle-Microsphere Composite as a Drug Carrier to Improve Lung-Targeting Specificity for Lung Cancer.

Authors:  Qianqian Zhang; Jianwei Bao; Tijie Duan; Minxing Hu; Yuting He; Junwei Wang; Rongfeng Hu; Jihui Tang
Journal:  Pharmaceutics       Date:  2022-02-25       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.